Functional testing protocols are thought to be the gold standard for the exploration of the immune system. However, in terms of routine analysis, they present numerous drawbacks and consequently their use is mainly limited to research applications. In the clinical context of septic shock, characterized by marked lymphocyte alterations, a new approach for lymphocyte intracellular cytokine measurement in whole blood upon was evaluated in a proof-of-concept study. Following lymphocyte activation, simultaneous intracellular labeling of Interferon-γ (IFN-γ), Tumor Necrosis Factor-α (TNF-α), and Interleukin-2 (IL-2) was performed in CD4 + and CD8 + T cells (identified by surface marking). The analysis was carried out by flow cytometry (6 colors). Results obtained in septic patients (n = 22) were compared to those of healthy volunteers (n = 8). Independently of lymphopenia, there were significant differences between groups. In particular there was significant decrease in the production of IL-2 and TNF-α in septic patients, while the production of IFN-γ was not significantly altered. Polyfunctional results showed that patients presented with increased percentages of triple negative lymphocytes. In contrast, volunteers had higher proportions of triple positive cells. The approach could be performed in a robust and consistent way, taking 4.5 h to complete. Moreover, clear differences could be observed between clinical groups with this modified method. These characteristics illustrate the potential of this novel whole blood protocol for clinical applications. However, further research is required to determine the applicability compared to alternative test and to evaluate clinical performances in larger cohorts of patients.
Introduction
In clinical immunology laboratories, functional testing remains the gold standard because it directly measures the capacity of a cell population to respond to an immune challenge [1, 2] . However, although providing excellent insights regarding pathophysiology, this approach remains barely usable for routine clinical monitoring due to several drawbacks (e.g., long incubation time, lengthy cell purification procedures, cell permeabilization, several staining steps, and numerous wash cycles). As a consequence, these protocols remain difficult to be standardized and thus they do not easily fulfil criteria for certification and accreditation of clinical laboratories [3] . Thus, a major challenge is therefore to bring functional testing to routine clinical practice.
Among immune functional assays, measurement of intracellular cytokines by flow cytometry appears as one of the most helpful [4] . It is able to determine both cell functionality and phenotype, while enumerating them. For instance, it is frequently used to characterize immune responses to infectious diseases, assess pyrogenicity of solutions, and measure immunogenicity during clinical trials of vaccines [4] [5] [6] . However, this assay remains time-consuming (about 6-8 h for completion, including several technical steps) and is consequently not used in clinical monitoring except for rare conditions (e.g., immune deficiencies, [1, 7] ).
We recently reported a novel approach to intracellular staining for flow cytometry that uses whole blood, and which is both rapid and robust [7] . Based on a similar approach, the aim herein was to assess simultaneous measurement of TNF-α, IFN-γ, and IL-2 in CD4 and CD8T cells in clinical samples. This proof of concept study was performed in the clinical context of septic shock in which T cells are believed to have an exhausted phenotype characterized by decreased cytokine production capacity [8] .
Materials and methods

Study population
Twenty-two septic shock patients (according to the diagnostic criteria of the International Guidelines for Management of Severe Sepsis and Septic Shock [9] ) admitted to the surgical ICU of E. Herriot Hospital (Lyon University hospitals) were enrolled in the study. This work is part of a comprehensive study of immune dysfunctions induced in ICUs (NCT02803346) which has been submitted to an ethics committee and approved by the institutional review board and registered with the French Ministry of Higher Education and Research (#DC-2008-509). Blood was collected in heparin coated tubes. Clinical and biological data were collected during the follow-up period (until 28 days)
Research reagents
Tubes (12 × 75 mm) containing a dry coating of a mixture of Phorbol 12-Myristate 13-Acetate (PMA) and Ionomycin to stimulate the production of cytokines by T cells, and Brefeldin A (BrefA) to block cytokine secretion via the Golgi apparatus. In addition, tubes (12 × 75 mm) containing a dry coating of conjugated antibodies formulated for this assay were also used: Fluorescein Isothiocyanate (FITC)-labeled anti-IFNγ (clone 45.15), Phycoerythrin (PE)-labeled anti-TNF-α (clone IPM2), PE-Cyanine 7 (PC7)-labeled anti-IL-2 (clone MQ1-17H12), Alexa Fluor 700 (A700)-labeled anti-CD8 (clone B9.11), Alexa Fluor 750 (A750)-labeled anti-CD3 (UCHT1) and Pacific Blue (PB)-labeled anti-CD4 (13B8.2). These reagents are custom-made, optimized for this study by Beckman Coulter Immunotech (Marseille, France).
Intracellular staining procedure
A schematic protocol representation is presented in Fig. 1 . Briefly, 50 microliters of undiluted fresh whole blood (< 2 h after sampling) was directly added to the stimulation tube (PMA-Ionomycin-BrefA), or to an empty control tube, and incubated 3 h at 37°C. Samples were then treated according to the regular PERFIX-no centrifuge (nc) procedure (Beckman Coulter, Brea, CA, US). Briefly, 25 μL of PERFIX-nc fixative reagent was added and the sample incubated for 15 min at room temperature in the dark, 2 mL PBS was then added and the tubes centrifuged at 150g for 5 min at 10°C, the supernatant was aspirated, and 25 μL of FBS were added to the pellet. Samples were then concomitantly permeabilized and stained for 45 min at room temperature in the dark (dried antibodies were resuspended extemporaneously with 300 μL permeabilizing reagent). The cells were then washed with 3 mL PERFIX-nc final reagent. The pellet was finally resuspended by adding 500 μL of PERFIX-nc final reagent. The entire protocol needed approximately 4.5 h to be completed.
Flow cytometry data acquisition and analysis
Data acquisition was performed on a Navios Flow Cytometer (Beckman Coulter). Our instrument was daily calibrated with Flowcheck Pro Fluorospheres (Beckman Coulter) to control optical alignment and fluidic system and Sphero Rainbow Calibration 
Statistical analysis
Results (% positive cells and MFI) were expressed as individual values and medians ± IQR (interquartile range). Results for the three cytokines (TNF-α, IFN-γ, and IL-2) in both T cell subpopulations (CD4 + and CD8 + ) with or without PMA-Ionomycin challenge among healthy volunteers and septic shock patients were compared, using the nonparametric Mann-Whitney U test or Wilcoxon paired test. Correlations were investigated using the Spearman correlation test. Statistical analyses were performed with GraphPad Prism® software (version 5.0; GraphPad Software, La Jolla, CA, US). A p-value < 0.05 was considered as statistically significant.
Results
Patients and healthy volunteers
Twenty-two septic shock patients (sampled during first 48 h after diagnosis) and eight healthy controls were included. Five patients were sampled a second time at D3-4. At onset of shock, the median 
Intracellular cytokines
At D1-2 expression of TNF-α, IFN-γ, and IL-2 in both T cell subpopulations was statistically higher following PMA-Ionomycin challenge compared to non-stimulated control, either in healthy subjects or patients (p < 0.0001). This was observed when results were expressed either as a proportion of positive cells (Fig. 3) or MFI (Fig. 4) . The proportion of CD4T cells expressing TNF-α (p = 0.0002) and IL-2 (p = 0.0007) as well as the proportion of CD8 + T cells expressing IL-2 (p = 0.0011) after stimulation were significantly lower among septic shock patients than healthy volunteers (Fig. 3) . Similarly, significant differences were found following PMA-Ionomycin stimulation between patients and healthy volunteers for TNF-α and IL-2 MFI of both CD4 + (p = 0.0106, and p = 0.0121, respectively) and CD8 + T cells, (p = 0.0157 and p = 0.0053, respectively). No significant difference was observed in the kinetic study between patients sampled both at D1-2 and D3-4 (data not shown). Polyfunctional results (from tree analysis, Fig. 5A ) are exhaustively presented in Table 2 . Illustrative examples are provided in Fig. 5B . For instance, septic patients presented with increased percentages of triple negative CD4 + T cells (p: 0.0001). In contrast, volunteers had more cells simultaneously positive for the 3 measured cytokines both in CD4 + T cells (p: 0.009) and CD8 + T cells (p: 0.003). We did not find any association between polyfunctional results and mortality. Of note, as controls are slightly younger than patients, the potential effect of age should be ruled out in further study.
Correlations
We did not find any significant correlations between CD4 and CD8 T cell counts and intracellular cytokine expressions (% positive cells and MFI). There was only one significant correlation (IL-2 production and CD8 T cell 
Discussion
In the present work a new protocol for the quantification of intracellular cytokines in T lymphocytes was assessed. The approach, based on whole blood (50 μL), is straightforward and allows the simultaneously measurement of three cytokines (TNF-α, IFN-γ, and IL-2) in subsets defined by the addition of two surface markers (CD4 and CD8). The entire protocol takes approximately 4.5 h to be completed, which seems to be quicker when compared to the usual published intracellular cytokine detection protocols that take up to 8 h [4, 10, 11] . In addition, the dry coating of reagents may improve standardization by reducing the pipetting steps and permitting storage at room temperature. Similar whole blood protocols reported in the literature [4, 10] have certain limitations compared to the one presently reported: for instance the initial incubation requires 6 h (2 h to stimulate cells, followed by 4 h-incubation to block cytokine secretion with brefeldin) instead of only 3 h herein, a greater number of washing steps, no dried reagents (including brefeldin) and antibodies, and reagents cannot be stored at room temperature. As we did not perform usual protocol at the same time in the present study, strict comparison of technical aspects remains to be done. That said, with only a few manual steps, the present protocol allows the technician to perform this protocol among other routine tasks. The present results aggregate with those obtained in monocytes regarding TNF-α production [7] . Taken together, they tend to highlight practical improvements in intracellular cytokine measurement.
In the delayed step of septic shock, exhaustion of T cells characterized by a loss of function (e.g. proliferation) and decrease in cytokine release is commonly described [8, 12] . With the present protocol, as expected, cytokine results significantly differentiated septic shock patients from healthy volunteers. Both in CD4 + and CD8 + T cells, TNF-α and IL-2 synthesis was significantly reduced. Based on the chronology of T cell exhaustion (i.e., the first cytokine production to be stopped is IL-2, then TNF-α, and finally IFN-γ), septic patients in our study seem to be in a rather late phase of the process (loss of IL-2 and TNF-α), but are not in the latest stage since production of IFN-γ is maintained [13] .
These results could be explained by analyses having been performed 1 or 2 days following the onset of septic shock, while the decrease of IFN-γ production along with impairment of other functions (e.g., proliferation) would occur later. Nevertheless, in few patients with additional samples at D3-4, no significant difference could be further detected. That said, polyfunctional analysis revealed that IFN-γ production may still be partially altered since we observed significant differences between controls and septic patients when focusing on triple positive cells both in CD4T and CD8T cells. That said, decreased IFN-γ Results are represented as individualized points along with the median and IQR.
remains a key pathologic hallmark of sepsis and this aspect deserves to be further explored in response to more physiologic activators (e.g., TCR agonists). From a therapeutically perspective, knowing that septic lymphocytes did not enter final stage of exhaustion reinforces the potential of rejuvenating them with IL-7 [8, 14] . There was no correlation between the absolute value of CD4 + or CD8 + T cells and their ability to produce cytokines. This illustrates the independence of lymphocyte functionality from lymphopenia and illustrates the potential interest of using functional testing to finely characterize patients. For instance, on the basis of a polyfunctional protocol, Snyder et al. could predict the risk of developing CMV infection in patients who received a lung transplant [15] . That said, the clinical interest of the present approach remains to be assessed. The study does, however, present certain limitations. Firstly, this test is based on antigen-independent stimulation of the lymphocytes. Thus, flow cytometry may not be suitable for antigen stimulation as assessed by other techniques (e.g., ELISPOT). In addition, as a proof-ofconcept study, the main objective of the present work was to assess feasibility of this whole blood protocol in clinical samples. Thus, comparison to other methods for assessing intracellular cytokines production was not made, and this remains to be performed. In line with this proof of concept objective, only 3 cytokines were assessed in a relatively small number of patients were included and no conclusions as to clinical outcomes could be made (mortality, occurrence of nosocomial infections). It is particularly true for investigating the potential of polyfunctional analysis (including additional cytokines such as IL-4 or IL-10) that would be likely fully revealed in large cohort of patients allowing robust statistics. This work now deserves to be widely assessed and validated in a larger ICU population, and if possible in multicenter studies.
In conclusion, these preliminary results indicate the feasibility of this novel whole blood protocol. Its simplicity, robustness, and rapidity allow it to be integrated into a routine work load or in the monitoring of clinical trials. Beyond septic shock and ICU patients, it appears reasonable to envisage a wider use in other clinical situations where the assessment of intracellular cytokine synthesis might help in monitoring immunosuppressed patients (e.g., transplantation, cancer, immune deficiencies) or treatments modulating immune responses (e.g., biotherapies). 
